[{"NetIncomeLossConverted_1_Q3_USD":-36719000.0,"NetIncomeLossConverted_3_Q3_USD":-101657000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-109839000.0,"CommonStockSharesOutstanding_0_Q3_shares":136392256.0,"StockholdersEquity_0_Q3_USD":775047000.0,"EarningsPerShareBasic_1_Q3_USD":-0.27,"EarningsPerShareBasic_3_Q3_USD":-0.79,"RevenuesConverted_1_Q3_USD":26299000.0,"RevenuesConverted_3_Q3_USD":68197000.0,"Assets_0_Q3_USD":1095473000.0,"CommonStockSharesConverted_0_Q3_shares":136392256.0,"Ticker":"ADPT","CIK":"1478320","name":"ADAPTIVE BIOTECHNOLOGIES CORP","OfficialName":"Adaptive Biotechnologies Corporation Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1463975665.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201110"}]